• 175 pages • 40 Exhibits • 100+ Company Profiles • Report #T650 PUBLISHINGJanuary2017
This report will assess the current status of technology and product development of nanotechnologies for therapeutic and diagnostic applications, with a forward-looking outlook on the anticipated timing and relative impact on existing diagnostic or therapeutic markets and new clinical applications and markets enabled by nanotechnology advances in medicine. The report will detail the developmental and market status of major nanomedical technology categories, including drug delivery, drugs and therapies (e.g., diabetes, antimicrobial resistance, Alzheimer’s Disease, infectious disease, arthritis, and others), nanotechnology in biomaterials, nanomedicine in personalized treatments, diagnostics (i.e., in vivo imaging and in vitro diagnostics), as well as a review of a wide range of emerging nanomedical applications. The report will detail the ethical, regulatory, legal, policy, government/private funding, and other drivers and limiters of nanomedical technologies in global markets. The report will seek to characterize the size of the market opportunities for nanomedicine based on penetration of markets otherwise served by non-nanomedical technologies, the current and emerging competitive landscape for nanomedical applications. The report will profile over 100 active companies developing nanomedical products.
See the table of contents and list of exhibits at link.
MedMarket Diligence Reports are produced through primary and secondary research. Primary research includes interviews with clinicians, industry representatives, and other stakeholders in the market for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data includes SEC filings; company annual reports; regional, federal, and international datasets; brokerage other investment reports; and other independent market research is used to corroborate and support assessments and projections. Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.
Global Nanomedical Technologies, Markets and Opportunities, 2016-2021
Purchaseonline or fax yourorder form.
Reports library access is also available through annual contract.
Refund Policy: MedMarket Diligence print products are refundable if returned in salable condition within 30 (thirty) days of purchase date. Electronic products (PDF, online database subscription) are non-refundable; clients are urged to review content on mediligence.com or contact MedMarket Diligence directly via phone or email in advance of purchase to ensure that electronic products will meet customer needs.